You are now leaving GSK’s website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.

NP-AU-NA-WCNT-250004 Date of Approval July 2025.

Skip to content
Other GSK Websites
  • GSKproThe GSK corporate website
  • GSKmedGSKmed
  • GSK.comGSK.com
GSK Logo
 
  • Communication preferences
Search

Report adverse event

GSK Logo

For Australian Healthcare Professionals

  • Home
  • Therapy areas
    • Respiratory
    • Vaccine-preventable diseases
    • Oncology
  • CPD hub
  • Contact us

Get in touch

This site is an information service for Australian healthcare professionals only. If you are a patient seeking medical advice, please consult your healthcare professional.

To discuss educational events or any other information, please click on the link below.

Contact us

  • Partnerships
  • Supported Studies Programme
  • GSK Study Register (Clinical Trial Data and Trial Recruitment)
  • Terms of use
  • Privacy Notice
  • Sitemap
Australia flag

Trade marks are owned by or licensed to the GSK group of companies. ©2024 GSK group of companies or its licensor. For information on GSK products or to report an adverse event involving a GSK product, please contact GSK Medical Information on 1800 033 109. GlaxoSmithKline Australia Pty Ltd ABN 47 100 162 481, Melbourne, VIC.